The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer

AKM Claessens, Reinier Timman, Jan van Busschbach, JM Bouma, JM Rademaker-Lakhai, FLG Erdkamp, VC Tjan-Heijnen, Monique Bos

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
8 Downloads (Pure)
Original languageEnglish
Pages (from-to)677-685
Number of pages9
JournalBreast Cancer Research and Treatment
Publication statusPublished - 2020

Cite this